Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)
Market Closed
2 Apr, 22:00
MSE ₹
218. 20
+1
+0.46%
₹
- Market Cap
34.78 P/E Ratio
5% Div Yield
510 Volume
0 Eps
₹ 217.2
Previous Close Day Range
213.9 219
Year Range
109.42 328.02
Summary
JAGSNPHARM closed today higher at ₹218.2, an increase of 0.46% from yesterday's close, completing a monthly decrease of -1.42% or ₹3.15. Over the past 12 months, JAGSNPHARM stock lost -10.81%.
JAGSNPHARM is not paying dividends to its shareholders.
The last earnings report, released on Jan 31, 2025, exceeded the consensus estimates by 4.82%. On average, the company has surpassed earnings expectations by 3.02%, based on the last three reports.
Jagsonpal Pharmaceuticals Limited has completed 1 stock splits, with the recent split occurring on Jan 08, 2025.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).
Want to track JAGSNPHARM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
JAGSNPHARM Chart
Loading, please wait...
Jagsonpal Pharmaceuticals Limited Dividends
| JAGSNPHARM 6 months ago Estimated | Other | ₹5 Per Share |
| JAGSNPHARM 6 months ago | Other | ₹5 Per Share |
| JAGSNPHARM 21 Aug 2023 | Other | ₹5 Per Share |
| JAGSNPHARM 29 Oct 2021 | Other | ₹4 Per Share |
| JAGSNPHARM 22 Sep 2021 | Other | ₹1 Per Share |
| JAGSNPHARM 22 Sep 2020 | Other | ₹0.5 Per Share |
Jagsonpal Pharmaceuticals Limited Earnings
| 31 Jan 2025 Date | | - Cons. EPS | 4.82 EPS |
| 1 Nov 2024 Date | | - Cons. EPS | - EPS |
| 23 Oct 2024 Date | | - Cons. EPS | 4.25 EPS |
| 7 Aug 2024 Date | | - Cons. EPS | 1.93 EPS |
| 31 Jul 2024 Date | | - Cons. EPS | - EPS |
| JAGSNPHARM 6 months ago Estimated | Other | ₹5 Per Share |
| JAGSNPHARM 6 months ago | Other | ₹5 Per Share |
| JAGSNPHARM 21 Aug 2023 | Other | ₹5 Per Share |
| JAGSNPHARM 29 Oct 2021 | Other | ₹4 Per Share |
| JAGSNPHARM 22 Sep 2021 | Other | ₹1 Per Share |
| JAGSNPHARM 22 Sep 2020 | Other | ₹0.5 Per Share |
| 31 Jan 2025 Date | | - Cons. EPS | 4.82 EPS |
| 1 Nov 2024 Date | | - Cons. EPS | - EPS |
| 23 Oct 2024 Date | | - Cons. EPS | 4.25 EPS |
| 7 Aug 2024 Date | | - Cons. EPS | 1.93 EPS |
| 31 Jul 2024 Date | | - Cons. EPS | - EPS |
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) FAQ
What is the stock price today?
The current price is ₹218.20.
On which exchange is it traded?
Jagsonpal Pharmaceuticals Limited is listed on XNSE.
What is its stock symbol?
The ticker symbol is JAGSNPHARM.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Jagsonpal Pharmaceuticals Limited ever had a stock split?
Jagsonpal Pharmaceuticals Limited had 1 splits and the recent split was on Jan 08, 2025.
Jagsonpal Pharmaceuticals Limited Profile
| Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Manish Gupta CEO | MSE Exchange | INE048B01027 ISIN |
| IN Country | 940 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Jagsonpal Pharmaceuticals Limited is a renowned name in the pharmaceutical industry with a strong focus on manufacturing and trading a diverse range of pharmaceutical products and active pharmaceutical ingredients. Since its inception in 1978, the company has established a strong footprint not only in India but also in various international markets. Jagsonpal Pharmaceuticals specializes in areas such as women's health, pain and analgesics, and general medicine, showcasing a commitment towards addressing a wide spectrum of health issues through its innovative solutions. Headquartered in New Delhi, India, the company stands out for its extensive experience and dedication to quality in the pharmaceutical sector.
Products and Services
Jagsonpal Pharmaceuticals Limited offers a comprehensive array of pharmaceutical formulations and over-the-counter drugs, tailored to meet the specific needs of patients across different therapeutic areas. Below is a detailed list of their products and services:
- Gynaecology: Their range in gynaecology aims to address various women's health issues, providing effective treatments and medications designed specifically for women. The offerings include a variety of formulations that cater to hormonal balance, fertility treatments, and overall women's health.
- Orthopaedics: Focused on the treatment and management of orthopaedic conditions, Jagsonpal Pharmaceuticals presents a selection of pain and analgesics products. These are formulated to alleviate pain and inflammation, aiding in the recovery and management of musculoskeletal disorders.
- Allergy Management: The company also specializes in the development and provision of allergy management medications. These products aim to offer relief from allergic reactions, improving patients' quality of life who suffer from various types of allergies.
- Pharmaceutical Formulations: Jagsonpal Pharmaceuticals excels in producing high-quality pharmaceutical formulations. These include tablets, softgels, injections, capsules, and syrups, catering to a broad array of health conditions and ensuring versatile therapeutic options for healthcare providers and patients alike.
- Over The Counter Drugs: Besides prescription medications, the company offers a range of over-the-counter (OTC) drugs. These products are designed to address common health concerns and are available without the need for a prescription, providing convenient and accessible healthcare solutions to the general public.
Contact Information
Address: T-210 J, Shahpur Jat, New Delhi, India, 110049
Phone: 91 12 4440 6710
Website: https://www.jagsonpal.com
2025 © Marketlog. All Rights Reserved.
